SIR -Mapping efforts to characterize the genetic basis of schizophrenia have indicated chromosome 13q32 as a potential susceptibility locus. In 2002, Chumakov et al reported an association (since replicated) for schizophrenia with single-nucleotide polymorphisms (SNPs) on chromosome 13q32 at the G72/G30 locus. [1] [2] [3] Evidence for linkage at this locus in our sample (NPL ¼ 2.95, P ¼ 0.001 at D13s174 (Mulle et al, 2005 4 )) encouraged us to investigate this association. We obtained 159 trios from the NIMH Genetics Initiative (66 trios) and the Western Psychiatric Institute and Clinic at University of Pittsburgh (93 trios), and genotyped 11 associated SNP markers as reported by Chumakov et al. Despite evidence for linkage to this region, we fail to find evidence for association at the G72/G30 locus.
No evidence for association to the G72/G30 locus in an independent sample of schizophrenia families SIR -Mapping efforts to characterize the genetic basis of schizophrenia have indicated chromosome 13q32 as a potential susceptibility locus. In 2002, Chumakov et al reported an association (since replicated) for schizophrenia with single-nucleotide polymorphisms (SNPs) on chromosome 13q32 at the G72/G30 locus. [1] [2] [3] Evidence for linkage at this locus in our sample (NPL ¼ 2.95, P ¼ 0.001 at D13s174 (Mulle et al, 2005 4 )) encouraged us to investigate this association. We obtained 159 trios from the NIMH Genetics Initiative (66 trios) and the Western Psychiatric Institute and Clinic at University of Pittsburgh (93 trios), and genotyped 11 associated SNP markers as reported by Chumakov et al. Despite evidence for linkage to this region, we fail to find evidence for association at the G72/G30 locus.
Ascertainment of schizophrenia trios has been previously described, for both the NIMH sample 5 and the Pittsburgh sample. 6 We selected pedigrees for our study if the pedigree had a case and DNAs from both parents were available. We obtained 66 trios from the NIMH resource, and 93 trios from the Pittsburgh sample. A total of 11 SNPs were selected for genotyping based on evidence for statistically significant association with schizophrenia as published in Chumakov et al. SNPs were genotyped using Taqman genotyping technology (ABI), in a 384-well format with 10 ng of DNA per reaction. For data quality purposes, at least 15% of the sample was genotyped in duplicate for each SNP assayed. Out of 4750 replicates, zero discrepancies existed (average rate of missing data ¼ 3%). The TDT statistic, which accounts for transmission of alleles from heterozygous parents, was computed according to Spielman and Ewens. 7 Parental genotypes were not imputed.
The results of TDT analysis for individual SNPs are shown in Table 1 , which shows the results of Chumakov et al's case-control association study side by side with the results for the TDT from our sample (where the putative associated allele was reported, results are shown for that allele). No SNP shows evidence for association with schizophrenia. We have evidence for linkage in a subset (n ¼ 33) of these families, and TDT analysis in the linkage sample, a separate set of 100 trios, and the entire sample combined, revealed almost no evidence for association (see Table 2 for stratified analysis). Results for SNP M4 approach statistical significance (P ¼ 0.04 in whole sample, P ¼ 0.01 in linkage sample, uncorrected for multiple tests).
An a priori analysis of power revealed that in our sample of 159 trios, at minor allele frequencies indicated by Chumakov (0.3-0.5), we have greater than 90% power to detect a distortion in transmission from the expected 50 : 50 ratio, for genotype relative risks as low as 1.7. Previous reports imply that the effect at the G72 locus may be slightly smaller (odds ratios estimates are 1.3-1.45 1, 8 ). This study may therefore be underpowered to detect the small effects reported by the previous two studies. However, the evidence for association in Tables 1  and 2 fail to reveal even a small trend toward overtransmission, particularly at SNPs M12-24, where both prior studies achieved the most significant evidence for association. In our sample, the allele previously reported as associated is frequently untransmitted exactly as often as it is transmitted. Furthermore, our linkage findings imply that a subset of our families are 'loaded' for a schizophrenia susceptibility locus on chromosome 13q32; therefore, our prior probability of finding evidence for association from linkage disequilibrium is increased.
Several explanations exist to explain the discrepancy between our results, and those of prior studies. Chumakov et al tested SNPs in a French Canadian sample, and Schumacher et al used a German population. It is possible that these populations have causative alleles for schizophrenia that are distinct from the alleles that cause schizophrenia in the population in our study. Our sample population is 84% Caucasian, 9% African American, and the remainder of the study population is comprised of a mix of different races. In order to minimize the effects of this heterogeneity, we used the TDT; by design, the TDT is robust to issues of population substructure. 7 However, it is possible that residual effects of heterogeneity have masked an association in the current analysis. It is worthwhile to note that for SNPs M12, M15, M19, and M23, the SNP reported as more frequent in cases in the Chumakov study is actually reported as less frequent in cases by Schumacher et al. 1, 8 Barring an error in labeling of alleles or samples, this implies that these populations are truly different, and the results from each casecontrol analysis may not be generalizable to other populations. Chumakov et al tested a total of 191 SNPs and report 11 statistically significant associa- tions. In total, 10 P-values less than 0.05 are expected under the null hypothesis; it is therefore possible that their results are false positives. It is also possible that the differences in allele frequencies seen by Chumakov et al and Schumacher et al are confounded by subtle differences in population structure between cases and controls, unrelated to the phenotype of schizophrenia.
Evidence is strong that a schizophrenia susceptibility locus exists on chromosome 13q32. [9] [10] [11] The exact nature of this susceptibility locus remains to be identified. Detailed association studies with a very dense map of SNPs in well-phenotyped populations are an appropriate way to investigate the genetic basis of schizophrenia. 
